Tissue Regenix Group plc (LON:TRX – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 35 ($0.45) and last traded at GBX 35.42 ($0.46), with a volume of 27614 shares changing hands. The stock had previously closed at GBX 36.50 ($0.47).
Tissue Regenix Group Stock Performance
The stock has a market capitalization of £31.93 million, a price-to-earnings ratio of -36.57 and a beta of 1.61. The company has a debt-to-equity ratio of 31.16, a current ratio of 4.03 and a quick ratio of 2.36. The stock has a 50-day moving average of GBX 50.24 and a 200 day moving average of GBX 55.07.
Tissue Regenix Group Company Profile
Tissue Regenix is a leading medical device company in regenerative medicine. The Company’s patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient’s body that can be used to repair diseased or damaged body structures.
Featured Stories
- Five stocks we like better than Tissue Regenix Group
- Breakout Stocks: What They Are and How to Identify Them
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Stock Average Calculator
- NVIDIA Insiders Sell: This Is What It Means for the Market
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
